{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:23:39Z","timestamp":1792725819038,"version":"4.5.0"},"reference-count":25,"publisher":"American Diabetes Association","issue":"5","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":3782,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The NOD mouse strain has been widely used to investigate the pathology and genetic susceptibility for type 1 diabetes. Induced pluripotent stem cells (iPSCs) derived from this unique mouse strain would enable new strategies for investigating type 1 diabetes pathogenesis and potential therapeutic targets. The objective of this study was to determine whether somatic fibroblasts from NOD mice could be reprogrammed to become iPSCs, providing an alternative source of stem cells for the production of genetically modified NOD cells and mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Adult tail-tip fibroblasts from male NOD mice were reprogrammed by retroviral transduction of the coding sequences of three transcription factors, OCT4, SOX2, and KLF4, in combination with a histone deacetylase inhibitor, valproic acid.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Eighteen NOD iPSC lines were generated, and three of these cell lines were further characterized. All three cell lines exhibited silencing of the three reprogramming transgenes and reactivation of endogenous pluripotent markers (OCT4, SOX2, NANOG, REX1, and SSEA1). These NOD iPSCs readily differentiated in vitro to form embryoid bodies and in vivo by teratoma formation in immunodeficient mice. Moreover, NOD iPSCs were successfully transfected with a reporter transgene and were capable of contributing to the inner cell mass of C57BL\/6 blastocysts, leading to the generation of a chimeric mouse.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Adult tail-tip fibroblasts from NOD mice can be reprogrammed, without constitutive ectopic expression of transcription factors, to produce iPSCs that exhibit classic mouse embryonic stem cell (ESC) features. These NOD iPSCs can be maintained and propagated under normal ESC culture conditions to produce genetically altered cell lines, differentiated cells, and chimeric mice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db10-1540","type":"journal-article","created":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T03:54:47Z","timestamp":1301975687000},"page":"1393-1398","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":19,"title":["Generation of Stable Pluripotent Stem Cells From NOD Mouse Tail-Tip Fibroblasts"],"prefix":"10.2337","volume":"60","author":[{"given":"Jun","family":"Liu","sequence":"first","affiliation":[{"name":"Centre for Reproduction and Development, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle P.","family":"Ashton","sequence":"additional","affiliation":[{"name":"Immunology and Diabetes Unit, St. Vincent\u2019s Institute, Fitzroy, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Sumer","sequence":"additional","affiliation":[{"name":"Centre for Reproduction and Development, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira K.","family":"O\u2019Bryan","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Developmental Biology, School of Biomedical Sciences, Monash University, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Brodnicki","sequence":"additional","affiliation":[{"name":"Immunology and Diabetes Unit, St. Vincent\u2019s Institute, Fitzroy, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Verma","sequence":"additional","affiliation":[{"name":"Centre for Reproduction and Development, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2011,4,23]]},"reference":[{"key":"2022031223353294400_B1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/9442","article-title":"The NOD mouse model of type 1 diabetes: as good as it gets?","volume":"5","author":"Atkinson","year":"1999","journal-title":"Nat Med"},{"key":"2022031223353294400_B2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-5793(99)00801-7","article-title":"Establishment of an embryonic stem (ES) cell line derived from a non-obese diabetic (NOD) mouse: in vivo differentiation into lymphocytes and potential for germ line transmission","volume":"455","author":"Nagafuchi","year":"1999","journal-title":"FEBS Lett"},{"key":"2022031223353294400_B3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature06968","article-title":"The ground state of embryonic stem cell self-renewal","volume":"453","author":"Ying","year":"2008","journal-title":"Nature"},{"key":"2022031223353294400_B4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.stem.2009.04.015","article-title":"Metastable pluripotent states in NOD-mouse-derived ESCs","volume":"4","author":"Hanna","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2022031223353294400_B5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nm.1996","article-title":"Validated germline-competent embryonic stem cell lines from nonobese diabetic mice","volume":"15","author":"Nichols","year":"2009","journal-title":"Nat Med"},{"key":"2022031223353294400_B6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1095\/biolreprod.109.079368","article-title":"Male germline and embryonic stem cell lines from NOD mice: efficient derivation of GS cells from a nonpermissive strain for ES cell derivation","volume":"81","author":"Ohta","year":"2009","journal-title":"Biol Reprod"},{"key":"2022031223353294400_B7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1634\/stemcells.2008-0974","article-title":"Pluripotin combined with leukemia inhibitory factor greatly promotes the derivation of embryonic stem cell lines from refractory strains","volume":"27","author":"Yang","year":"2009","journal-title":"Stem Cells"},{"key":"2022031223353294400_B8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"2022031223353294400_B9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature05934","article-title":"Generation of germline-competent induced pluripotent stem cells","volume":"448","author":"Okita","year":"2007","journal-title":"Nature"},{"key":"2022031223353294400_B10","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/nprot.2007.418","article-title":"Induction of pluripotent stem cells from fibroblast cultures","volume":"2","author":"Takahashi","year":"2007","journal-title":"Nat Protoc"},{"key":"2022031223353294400_B11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.stem.2008.01.004","article-title":"Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells","volume":"2","author":"Brambrink","year":"2008","journal-title":"Cell Stem Cell"},{"key":"2022031223353294400_B12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nmeth.1323","article-title":"Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon","volume":"6","author":"Yusa","year":"2009","journal-title":"Nat Methods"},{"key":"2022031223353294400_B13","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.0801677105","article-title":"Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson\u2019s disease","volume":"105","author":"Wernig","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031223353294400_B14","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.1152092","article-title":"Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin","volume":"318","author":"Hanna","year":"2007","journal-title":"Science"},{"key":"2022031223353294400_B15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/298623a0","article-title":"De novo methylation and expression of retroviral genomes during mouse embryogenesis","volume":"298","author":"J\u00e4hner","year":"1982","journal-title":"Nature"},{"key":"2022031223353294400_B16"},{"key":"2022031223353294400_B17"},{"key":"2022031223353294400_B18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/mrd.20983","article-title":"Stable transgene expression in human embryonic stem cells after simple chemical transfection","volume":"76","author":"Liu","year":"2009","journal-title":"Mol Reprod Dev"},{"key":"2022031223353294400_B19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nbt1374","article-title":"Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts","volume":"26","author":"Nakagawa","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2022031223353294400_B20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nbt.1502","article-title":"Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2","volume":"26","author":"Huangfu","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2022031223353294400_B21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nbt1418","article-title":"Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds","volume":"26","author":"Huangfu","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2022031223353294400_B22","first-page":"297","article-title":"X-chromosome instability in pluripotential stem cell lines derived from parthenogenetic embryos","volume":"74","author":"Robertson","year":"1983","journal-title":"J Embryol Exp Morphol"},{"key":"2022031223353294400_B23","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng1663","article-title":"Global hypomethylation of the genome in XX embryonic stem cells","volume":"37","author":"Zvetkova","year":"2005","journal-title":"Nat Genet"},{"key":"2022031223353294400_B24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nature05972","article-title":"New cell lines from mouse epiblast share defining features with human embryonic stem cells","volume":"448","author":"Tesar","year":"2007","journal-title":"Nature"},{"key":"2022031223353294400_B25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature05950","article-title":"Derivation of pluripotent epiblast stem cells from mammalian embryos","volume":"448","author":"Brons","year":"2007","journal-title":"Nature"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/60\/5\/1393\/400667\/1393.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/60\/5\/1393\/400667\/1393.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:25:20Z","timestamp":1667406320000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/60\/5\/1393\/33564\/Generation-of-Stable-Pluripotent-Stem-Cells-From"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,23]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,4,23]]},"published-print":{"date-parts":[[2011,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db10-1540","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,23]]}}}